Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

PR Newswire |

UPPSALA, Sweden, /PRNewswire/ --

New results from a Pfizer study on Ibrance® (palbociclib, Pfizer) of women with metastatic breast cancer demonstrate that DiviTum can provide fast evaluation of biologic effect demonstrating CDK 4/6 inhibition.

The study, presented at the ongoing AACR congress in Chicago, concluded that using DiviTum to measure cell proliferation in blood samples could potentially be used to assess cell cycle modulation by Ibrance®.

"We are pleased that DiviTum is included by Pfizer in their clinical development of Ibrance®. These positive results are in line with previously presented DiviTum data evaluating biologic effect of demonstrating CDK 4/6 inhibition in connection with treatment of breast cancer. The results take us yet another step closer to our vision of enabling the best possible treatment for cancer patients from day one" says Anders Rylander, CEO Biovica. 

Study ref. NCT02499146
http://www.abstractsonline.com/pp8/#!/4562/presentation/11185
https://congress-download.pfizer.com/Assets/Templates/file_pdf.aspx?docId=1743&c=1

More information:
Anders Rylander, CEO Biovica.
Phone: +46 (0)18-444-48-35,
E-mail: anders.rylander@biovica.com



This information was brought to you by Cision http://news.cision.com

http://news.cision.com/biovica-international-ab/r/positive-results-with-divitum--from-new-pfizer-study-presented-at-the-aacr-congress,c2497168

The following files are available for download:

 

Cision View original content:http://www.prnewswire.com/news-releases/biovica-international---positive-results-with-divitum-from-new-pfizer-study-presented-at-the-aacr-congress-300631000.html

SOURCE Biovica International AB

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

GTX Corp

GTX Corp, along with its subsidiaries, is engaged in design, development, manufacturing, distribution and sales of products and services in the GPS and BLE wearable technology personal location and wandering…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…